Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable/Potentially Resectable NSCLC”

Showing 5 of 0 results

Not applicableActive Not RecruitingNCT06243679
What this trial is testing

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

Who this might be right for
Resectable/Potentially Resectable NSCLC
Xiangya Hospital of Central South University 100
Early research (Phase 1)UnknownNCT05157542
What this trial is testing

Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Juan LI, MD 9
Testing effectiveness (Phase 2)Ended earlyNCT04512430
What this trial is testing

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Who this might be right for
Non Small Cell Lung CancerEGFR Gene Mutation
Fundación GECP 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07829744
What this trial is testing

Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Zhongshan Hospital 190
Not applicableUnknownNCT04540757
What this trial is testing

Impact on Quality of Life From Multi-modality Lung Cancer

Who this might be right for
Lung NeoplasmsQuality of Life
The Christie NHS Foundation Trust 66

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation